What is one of the major impacts of Carbapenem-resistant Enterobacteriaceae (CRE) on patients?

The major impact of Carbapenem-resistant Enterobacteriaceae (CRE) on patients is the increased morbidity and mortality rates associated with infections caused by these bacteria. CRE are known for their resistance to multiple antibiotics, making them difficult to treat. This resistance leads to prolonged infections, complications, and a higher likelihood of severe outcomes, including death in some cases. The ability of CRE to survive treatment poses significant challenges in managing infections, thus contributing to higher rates of illness and fatalities compared to infections caused by antibiotic-sensitive organisms.

Knowing this highlights the importance of infection control practices to prevent the spread of such resistant organisms in healthcare settings, as the implications for patient health can be dire.